The C57 BL/Ks/J db/db mouse develops hyperglycemia and has delayed gastric emptying which is improved with tegaserod, a partial 5-HT 4 agonist. AIMS: To determine regional gastric contractility alterations in C57 BL/Ks/J db/db mice and to determine the effects of serotonin and tegaserod. METHODS: Contractile effects of bethanechol, serotonin, and tegaserod in fundic, antral, and pyloric circular muscle were compared in C57 BL/Ks/J db/db mice and normal litter mates. Effects of tetrodotoxin, atropine, and 5-HT receptor antagonists were studied. RESULTS:
Introduction
Gastroparesis (delayed gastric emptying) is frequent in diabetic patients. It is a wellrecognized complication of long standing diabetes. Although classically gastroparesis occurs in insulin dependent diabetic patients, it also develops in type 2 or non-insulin dependent diabetes mellitus (15) . Gastroparesis is associated with antral hypomotility and perhaps pyloric dysfunction (2, 23) .
Treatment of gastroparesis is with prokinetic agents, which accelerate gastric emptying.
Tegaserod, an aminoguanidine indole compound, is a recently developed 5-HT 4 -partial agonist (1) . Activation of 5-HT 4 receptors triggers the release of neurotransmitters from the enteric nerves resulting in increased contractility and stimulation of the peristaltic reflex (10) .
Tegaserod has been shown to accelerate gastric emptying in some (6) , but not all studies (28) .
Strains of rats and mice with spontaneously developing hyperglycemia have been recognized as useful models to study the effects of diabetes. The Jackson Laboratory C57 BL/Ks/J db/db mouse spontaneously develops hyperglycemia (12) and is a model for non-insulin dependent diabetes mellitus (24) . Prior studies in this mouse strain have shown delayed gastric emptying (22) . Tegaserod, a partial 5-HT 4 agonist, accelerates gastric emptying in these diabetic mice (21) . Gastric muscle dysfunction has not been characterized in this diabetic mouse model and the effect of tegaserod on gastric contractility is not known.
The aims of these in vitro studies were twofold. First, to determine if there are regional alterations in gastric contractility in C57 BL/Ks/J db/db diabetic mice compared to normal mice.
We also investigated the muscarinic subtypes mediating cholinergic contractions to determine if alterations of muscarinic receptor subtypes may explain any alterations in gastric contractility. Second, to determine the effects and mechanisms of serotonin on regional gastric contractility in C57 BL/Ks/J db/db diabetic mice compared to normal mice.
Materials and Methods

Fundus, antrum, and pyloric muscle ring preparation
The Jackson Laboratory C57 BL/Ks/J db/db transgenic mouse (Jackson Laboratories, Bar Harbor, ME) and its normal control litter mates (females age 8-12 weeks old) were used in this study (13) . The phenotype of db/db mice includes early onset obesity and hyperglycemia (12) . This study was approved by the IACUC Committee at Temple University School of Medicine.
Mice were acclimated at our institution for 5 days before use. On the day of the study, the mouse was weighed. The mouse was sacrificed by CO 2 asphyxiation with subsequent removal of the stomach with pylorus and proximal duodenum. A blood sample was obtained for blood glucose concentration (Accu-Check, Roche-Diagnostics Corporation, Indianapolis, IN). The stomach was rinsed with Krebs-bicarbonate buffer (composition in mM: NaCl, 120; KCl, 4.6; CaCl 2 , 2.5; MgCl 2 , 1.2; NaHCO 3 , 22; NaH 2 PO 4 , 1.2, and glucose, 11.5; oxygenated with 95% O 2 , 5% CO 2 ; pH 7.4). Circular muscle rings were prepared from the fundus, antrum, and pylorus in the C57 BL/Ks/J db/db mouse and its normal control litter mates. In general, from one mouse, two fundic rings, two antral rings, and one pyloric ring were obtained. The rings were attached to isometric force transducers and suspended in 10 ml organ baths containing Krebs-bicarbonate buffer (temperature 37 o C). After a 30 min equilibration period, the preparations were stretched until the contractile response to acetylcholine 100 µM was maximal (L max ).
Experimental Protocols
Bethanechol concentration-response curves (CRCs) were performed in doses from 10 nM to 100 µM. Each concentration was added for 3 minutes with rinsing in between doses and resumption of baseline tone. High-potassium (80 mM), which causes muscle cell membrane depolarization, subsequent calcium entry, and muscle contraction, was also used to contact the muscle rings. For this, high-potassium Krebs solution replaced the normal Krebs solution surrounding the muscle ring in the in vitro muscle bath. The potassium-containing Krebs solutions were prepared by increasing the potassium concentration to 80 mM while decreasing the sodium concentration to maintain osmolality (26) .
Some studies have suggested that muscle dysfunction in neuropathy and diabetes can be due to alterations in muscarinic receptor subtypes mediating contractions (5) . Thus, the muscarinic receptor subtypes mediating cholinergic contractions were investigated in this study by determining the inhibitory effects of specific muscarinic receptor subtype antagonists on bethanechol-induced contractions. The M1 muscarinic subtype receptor antagonist pirenzepine, the M2 antagonist methoctramine, and the M3 antagonist 4-DAMP (Sigma Chemical Co., St Louis, MO) were used (27) . After an initial control contractile response to bethanechol 10 µM followed by rinsing, a receptor antagonist at 10 nM concentration, was added, followed in 10 minutes by addition of another application of bethanechol 10 µM. This was repeated with the receptor antagonist at 100 nM concentration. Ballwin, MO) were used to determine neural and receptor pathways mediating the serotonin contractile responses. After an initial control contractile response to serotonin 10 µM followed by rinsing, the receptor antagonist was added, followed in 10 minutes by addition of another application of serotonin 10 µM.
For experimental protocols with receptor antagonists, time controls were performed.
These control muscle strips were studied with the same protocol but without the addition of antagonists for which similar contractile responses were obtained. There were no changes in contractility over the 3 hour in vitro experimental protocols.
Additional studies with electric field stimulation (EFS) were used to activate the intrinsic enteric nerves. These were performed with the muscle strips suspended between platinum electrodes placed adjacent and parallel to the long axis of the muscle strip in the circular muscle direction. These electrodes were connected to an electric stimulator (Grass Stimulator Model At the end of each experimental protocol, the muscle length was measured. The muscle ring was removed, blotted dry with filter paper, and weighed (model GA110, Ohaus Corp.,
Florham Park, NJ). The cross sectional area was calculated using the relationship area = mass/(density x length), where the mass was in grams, the length was in centimeters, and the density was assumed to be 1.056 g/cm 3 (11, 31) . The accuracy of this method for determining cross-sectional surface area has been verified using previously optically derived measurements (31, 32) . Contractile results were expressed as muscle tension which normalized for differences in tissue strip size by dividing the absolute force of the contraction by the cross-sectional muscle area (kilograms per square centimeter).
Data Analysis
Contractile responses to bethanechol, potassium, serotonin, and tegaserod were measured 
Results
General observations
Experiments were performed in 46 C57 BL/Ks/J db/db diabetic mice and 48 normal control litter mates. In general, the C57 BL/Ks/J db/db diabetic mice were larger than the control litter mates. The body weights of the diabetic mice were greater than normal litter mates (41+1 vs 19+1 gm; p<0.001). Blood glucose concentrations were elevated in C57 BL/Ks/J db/db diabetic mice compared to normal control litter mates (478+17 vs 137+4 mg/dl; p<0.001).
Effects of bethanechol and potassium on fundic, antral and pyloric muscle
We first investigated the contractile responses in diabetic and control mice using both 
Effects of muscarinic receptor antagonists on bethanechol-induced contractions
We next investigated the muscarinic subtypes mediating the bethanechol-induced contraction to determine if there were alterations in the subtypes mediating the cholinergic contractile responses (Table 1 and Figure 4) . In both the normal and diabetic mice, the contractile response to bethanechol 10 µM were significantly inhibited by 10 nM of 4-DAMP in the fundus (75+5% and 71+4% inhibition, respectively) and antrum (53+10% and 43+10% inhibition, respectively). A higher concentration of 4-DAMP (100 nM) produced greater inhibition of the bethanechol-induced contractile responses (Table 1) . Pirenzepine and methoctramine did not have a significant effect on bethanechol-induced contractions at these concentrations (10 nM and 100 nM; Table 1 ).
Effects of serotonin on fundic, antral, and pyloric muscle
We next evaluated the effects of serotonin (5-hydroxytryptamine; 5-HT) on fundic, antral, and pyloric muscle rings from the diabetic and normal mice. Serotonin elicited concentration-dependent contractile responses of the fundus, antrum, and pylorus ( Figures 5 and   6 ). The contractions were significantly less than those to either acetylcholine or bethanechol. In normal mice, the contractile effect of serotonin was more pronounced in the fundus (44+11 gm/cm 2 ) than in the antrum (5+2 gm/cm 2 ) or pylorus (7+2 gm/cm 2 ) at the ED-max of 30 µM (Figure 6a, 6b, 6c) . The contractile effects to serotonin seen in diabetic mice (Figures 6d, 6e, 6f) were of similar magnitude as in normal mice (Figures 6a, 6b, 6c) .
Effects of antagonists on serotonin-induced contractions
The effects of neural and receptor inhibitors on the serotonin-induced contractions were studied. The contractile effects of serotonin 10 µM were reduced, but not significantly, by the neural blocker tetrodotoxin ( Table 2 ). The contractile effects of serotonin 10 µM were partially inhibited by atropine in the control mice (43+8% inhibition in the fundus and 61+10% inhibition in the antrum) with similar inhibitory effects in the diabetic mice ( Table 2 ). The 5-HT 1 receptor antagonist pindolol and the 5-HT 3 receptor antagonist Y25130 had no significant effect on serotonin-induced contractions. There was a small, but significant, inhibition seen with the 5-HT 4 receptor antagonist, GR113808 (1 µM) in both the fundus and antrum. There was also a small, but significant, inhibitory effect seen with the 5-HT 2 receptor antagonist cinanseron in the antrum, but not the fundus, of diabetic and normal mice ( Table 2) .
Effects of tegaserod
To further explore the role of 5-HT 4 receptors in mediating the serotonin-induced contractions, the effect of tegaserod on muscle rings were studied ( Figure 6 ). Tegaserod produced concentration-dependant contractions both in normal (figures 6a, 6b, 6c) and diabetic mice (figures 6d, 6e, 6f), which were also greater in the fundus than the antrum and pylorus as seen with serotonin. The tegaserod contractile responses were less than the serotonin responses except in the diabetic antrum, where they tended to be greater ( Figure 6 ).
Effects of electric field stimulation (EFS)
Electric field stimulation (EFS) at 16 Hz was used to activate the intrinsic nerves of fundic and antral muscle strips. EFS, at the parameters used, produced contractions of the fundus and antrum. EFS-induced contractions were inhibited by tetrodotoxin 1 µM or atropine 1 µM whereas ACh-induced contractions were abolished by atropine but not affected by tetrodotoxin. This indicates that EFS-induced contractions were primarily cholinergically mediated by activation of cholinergic nerves to release ACh which subsequently acts on muscarinic receptors to cause smooth muscle contraction. Tegaserod increased the EFS-induced contractions of the antrum in both the control and diabetic mice (Table 3 ). There was no significant effect of tegaserod on EFS-induced contractions of fundic muscle strips in either control or diabetic mice (Table 3) . Tegaserod had no effect on contractions induced by exogenous application of ACh 10 -4 M in either the fundus or antrum in the control and diabetic mice (data not shown).
Discussion
The Jackson Laboratory C57 BL/Ks/J db/db mouse, which spontaneously develops chronic hyperglycemia and obesity, is a model for Type 2 diabetes mellitus (12) . This mouse strain has delayed gastric emptying (22) making this animal model useful to investigate abnormalities in diabetic gastroparesis. This study shows that regional differences in gastric contractility are present in this mouse model of diabetic gastroparesis. Specifically, the gastric contractility to bethanechol was significantly decreased in the fundus, but increased in the pylorus compared to normal control littermates. In each of the fundus, antrum, and pyloric areas, the cholinergic contractile responses were mediated through muscarinic M3 subtype receptors as evidenced by the inhibitory effects of the M3 receptor antagonist 4-DAMP on cholinergic contractions.
Prior studies in diabetic gastroparesis, particularly human studies in type 1 diabetes mellitus, have shown the gastroparesis is associated with antral hypomotility (2). Some studies have also shown the presence of pyloric dysfunction, or pylorospasm (23) . Gastroparesis has also been described in type 2 diabetes mellitus (T2DM) (15) . Using the C57 BL/Ks/J db/db mouse model of T2DM with delayed gastric emptying (22) , this study suggests that the fundic hypomotility and pyloric hypercontractility, rather than antral hypomotility, play important roles for the delayed gastric emptying in diabetes. Our study primarily concentrated on muscle function in this diabetic model, and suggests smooth muscle dysfunction is present in diabetic gastroparesis as shown by the alterations in the contractile response to bethanechol and potassium. It is recognized that diabetic gastroparesis is classically thought to be due to impaired neural control of gastric motor function, possibly resulting from a vagal neuropathy. Abnormal neural innervation and neurotransmission of both inhibitory and excitatory neurotransmitters, interstitial cells of Cajal, and muscle function have been described (25, 30, 36) . Smooth muscle dysfunction has been previously suggested in streptozotocin-induced diabetic models (16, 33) .
Our study has also shown that serotonin (5-HT) has contractile effects in normal and diabetic mouse stomach. The contractile effects of serotonin were more prominent in the fundus than in the antrum or pylorus in both the diabetic and the normal mice. Interestingly, in contrast to the bethanechol contractions, the serotonin-induced contractions were similar in the two groups. A prior study has shown alterations of contractile responses to serotonin in gastric fundic smooth muscle from streptozotocin-induced diabetic rat (39) .
We investigated the mechanism of the serotonin eliciting contractions of the gastric Sumatriptan, a 5-HT 1 agonist, also induces relaxation of gastric fundus in man (34).
The 5-HT 4 partial agonist, tegaserod, accelerates gastric emptying in these diabetic mice (21) . This is analogous to the contractile effects of tegaserod seen in this in vitro study.
Interestingly, this acceleration of gastric emptying seen in vivo reportedly occurred at low doses, but not at high doses in diabetic mice and in normal mice (20, 21) . shown to increase gastric emptying in normal subjects and patients with gastroparesis (6, 37) .
In summary, this study shows that regional differences in gastric contractility are present in this mouse model of diabetic gastroparesis. Specifically, the gastric contractility to bethanechol was significantly decreased in the fundus, but increased in the pylorus with similar responses in the antrum. In each area, the cholinergic contractile responses appear to be mediated through M3 subtype muscarinic receptors. This study suggests that the fundic hypomotility and pyloric hypercontractility, rather than antral hypomotility, may play important roles for the delayed gastric emptying in diabetes. Serotonin was shown to have gastric contractile effects in normal and diabetic mice, being more prominent in the fundus than antrum. In addition to a cholinergic pathway, part of serotonin's contractile effect may be mediated through 5-HT 2 and 5-HT 4 receptors. Bethanechol caused concentration dependent contractions of the fundus, antrum, and pylorus.
These tracings are from a normal mouse using in vitro circular muscle rings. and tegaserod caused concentration-dependent contractions which were more pronounced in the fundus than in the antrum or pylorus in both diabetic and normal mice. The tegaserod contractile responses were generally significantly less than the serotonin responses except in the diabetic antrum, which tended to be greater.
